Israel Englander Legend Biotech Corp Call Options Transaction History

Millennium Management LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $3.16 Million - $4.58 Million	80,000 New	80,000 $3.54 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $1.57 Million - $2.08 Million	36,200 New	36,200 $1.75 Million

204

74.3M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.93B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.